Education
About Us
Working with TipRanks
Follow Us
Klotho Neurosciences, Inc. (KLTO)
:KLTO
KLTO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.21 - $13.10
Previous CloseN/A
Volume261.47K
Average Volume (3M)535.12K
Market Cap
$6.30M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)47.51K
Price to Earnings (P/E)―
Beta0.67
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding28,011,350
10 Day Avg. Volume69,822
30 Day Avg. Volume535,121
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Klotho Neurosciences News
PremiumCompany Announcements
Klotho Neurosciences Ends Licensing Agreement with Teleost
PremiumCompany Announcements
Klotho Neurosciences Extends CEO Contract with Stock Options
---
Options Prices
Currently, No data available
---
Ownership Overview
4.74% Insiders
0.29% Mutual Funds
2.27% Other Institutional Investors
92.70% Public Companies and
Individual Investors
KLTO FAQ
What was Klotho Neurosciences, Inc.’s price range in the past 12 months?
Klotho Neurosciences, Inc. lowest stock price was $0.21 and its highest was $13.10 in the past 12 months.
What is Klotho Neurosciences, Inc.’s market cap?
Klotho Neurosciences, Inc.’s market cap is $6.30M.
When is Klotho Neurosciences, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Klotho Neurosciences, Inc.’s earnings last quarter?
Currently, no data Available
Is Klotho Neurosciences, Inc. overvalued?
According to Wall Street analysts Klotho Neurosciences, Inc.’s price is currently Overvalued.
Does Klotho Neurosciences, Inc. pay dividends?
Klotho Neurosciences, Inc. does not currently pay dividends.
What is Klotho Neurosciences, Inc.’s EPS estimate?
Klotho Neurosciences, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Klotho Neurosciences, Inc. have?
Klotho Neurosciences, Inc. has 28,011,350 shares outstanding.
What happened to Klotho Neurosciences, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Klotho Neurosciences, Inc.?
Among the largest hedge funds holding Klotho Neurosciences, Inc.’s share is Fir Tree Inc.. It holds Klotho Neurosciences, Inc.’s shares valued at 0.
---
Company Description
Klotho Neurosciences, Inc.
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
---
Technical Analysis
ACADIA Pharmaceuticals
―
Biogen
―
Neurocrine
―
Vertex Pharmaceuticals
―
SAGE Therapeutics
―
---